CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4,732 enrolled
Drug / intervention
Clinical outcomesother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03673306
NCT03673306N/ACompleted

A Multicenter Retrospective Study on the Prognostic Impact of Pregnancy in Women With History of BRCA Mutated Breast Cancer

Jules Bordet Institute·observational·Posted Sep 17, 2018·Updated Dec 13, 2024

In Brief

An observational study evaluating Clinical outcomes for Breast Cancer. Completed, enrolled 4,732 participants across 81 sites in 26 countries.

Detailed Summary

The present study aims at refining the understanding of the effect of pregnancy on breast cancer outcomes in the specific population of BRCA mutated patients with known history of breast cancer.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesArgentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Brazil, Canada, France, Georgia, Germany, India, Israel, Italy, Lebanon, Mexico, Netherlands, Poland, Portugal, Romania, Serbia, Slovakia, South Korea, Spain, Sweden, Switzerland, United States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 17, 2018
Enrollment StartJan 16, 2017
Primary CompletionDec 1, 2023
TodayJul 2, 2026
Enrollment to primary: 6.9 yearsPosted 7.8 years ago

Interventions

Clinical outcomesother

Clinical outcomes